๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study

โœ Scribed by Milton Packer; Wilson S. Colucci; Lloyd Fisher; Barry M. Massie; John R. Teerlink; James B. Young; Chris J. Garratt

Book ID
119588785
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
78 KB
Volume
9
Category
Article
ISSN
1532-8414

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A PROSPECTIVE, BLINDED STUDY OF BIOIMPED
A PROSPECTIVE, BLINDED STUDY OF BIOIMPEDANCE VECTOR ANALYSIS AND BIOMARKER TESTING FOR THE PREDICTION OF WORSENING RENAL FUNCTION IN CONSECUTIVE PATIENTS WITH ACUTELY DECOMPENSATED HEART FAILURE: PRIMARY RESULTS OF THE BIOMONITORING AND CARDIORENAL SYNDROME IN HEART FAILURE (BIONICS-HF) TRIAL
โœ Berardinis, Benedetta De; Magrini, Laura; Gaggin, Hanna K.; Belcker, Arianna; Za ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 216 KB
Design and Rationale of the PROTECT Stud
Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function
โœ Beth Davison Weatherley; Gad Cotter; Howard C. Dittrich; Paul DeLucca; George A. ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 217 KB